jRCT2072230083进行中（未招募）不适用
Safety confirmation study with dMD-003 - Study to evaluate the safety of dMD-003 in patients scheduled to undergo uterine myomectomy -
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 入组人数
- 30
- 主要终点
- -
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Single Arm Study
- 干预模型
- Single Assignment
- 主要目的
- Treatment Purpose
- 盲法
- Open(masking Not Used)
入排标准
- 年龄范围
- 20age old over 至 No limit（—）
- 性别
- Female
入选标准
- •(1) Patients scheduled to undergo laparoscopic, laparoscopy-assisted, or open uterine myomectomy.
- •Other criteria.
排除标准
- •(1) Patients who have undergone surgery in the abdominal or pelvic cavity (excluding surgery for appendicitis).
- •(2) Patients with concurrent active pelvic inflammatory disease or peritonitis.
- •(3) Patients suspected of having moderate (stage III) or severe endometriosis according to the r-ASRM classification.
- •Other criteria.
结局指标
主要结局
-
Incidence of adverse events up to 12 weeks after surgery.
次要结局
未报告次要终点
研究者
相似试验
尚未招募
2 期
Safety confirmation study with dMD-003JPRN-jRCT2072230083Aihara Fumiaki30
招募中
不适用
Safety and performance confirmation study with dMD-003jRCT2032240323Mochida Pharmaceutical Co., Ltd.15
已完成
4 期
A clinical trial to study the effects of drug in pediatric subjects with complicated Skin & skin structure infection caused by Gram-positive PathogensCTRI/2009/091/000725Cubist Pharmaceuticals150
进行中（未招募）
1 期
A study of the safety of the new investigational drug CVN293 in healthy volunteers, and how CVN293 is taken up and processed by the human body.CTIS2023-506114-49-00Cerevance Inc.64
进行中（未招募）
不适用
Pilot study of dMD-002 in patients with neurovascular bundles injury during radical prostatectomyProstate cancerJPRN-jRCT2022210040akamura Masaki12